multivitamin, multi-mineral nutritional supplement with DHA
Dosage Form: tablet
Multi-Nate 30 DHA 275/400mg
Multi-Nate DHA Description
Multi-Nate 30 DHA 275/400 mg is a high-potency, multivitamin, multi-mineral nutritional supplement with DHA (Omega-3 Fatty Acid).
Each Multi-Nate 30 tablet contains:
Vitamin A (beta carotene) 3000 IU, 60% DV
Vitamin B (ascorbic acid) 120 mg, 200% DV
Vitamin D (as cholecalciferol) 400 IU, 100% DV
Vitamin E (as dl-alpha tocopheryl acetate) 30 mg, 100% DV
Vitamin B1 (as thiamine monoitrate) 1.8 mg, 120% DV
Vitamin B2 (as riboflavin) 4 mg, 235% DV
Niacin (as niacinamide) 20 mg, 100% DV
Vitamin B6 (as pyridoxine hydrochloride) 25 mg, 1250% DV
Folic Acid 1 mg, 250% DV
Vitamin B12 (as cyanocobalamin) 12 mcg, 200% DV
Calcium (as calcium carbonate) 200 mg, 20% DV
Iron (as ferrous bisglycinate and iron protein succinylate) 29 mg, 161% DV
Magnesium (as magnesium oxide) 25 mg, 6% DV
Zinc (as zinc oxide) 25 mg, 167% DV
Copper (as cupric oxide) 2 mg, 100% DV
Other Ingredients (Multi-Nate 30 tablet): Mono and Diglycerides, Croscarmellose Sodium, Microcrystalline Cellulose, Crospovidone, Maltodextrin, Stearic Acid, Magnesium Stearate, Silicon Dioxide, Acacia, Sodium Alginate, Polyethylene Glycol, Arabic Gum, Gelatin, Sucrose, Pea Starch, Cornstarch, Partially Hydrogenated Soybean Oil, Hydroxypropyl Methylcellulose, Dicalcium Phosphate, dl-alpha Tocopherol, Titanium Dioxide, Triacetin, Carmine Powder, Polysorbate, Riboflavin.
Contains Soy.
May contain povidone and polydextrose.
Contains NO artificial flavors or preservatives, yeast, wheat, gluten, nuts or milk-based by-products.
Each Multi-Nate DHA 275/400 mg softgel capsule contains:
275 mg Docosahexaenoic Acid (DHA) from 400 mg omega-3 fatty acids (tuna oil).
Omega-3 Fatty Acids (from tuna oil) 400 mg, Daily Value not established
Docosahexaenoic Acid (DHA) 275 mg
Other Ingredients (Multi-Nate DHA 275/400 mg softgel capsule): Gelatin, Water, Glycerin, Polysorbate 80.
Also contains Eicosapentaenoic Acid (EPA) and other Omega-3 Fatty Acids (from tuna oil).
Contains Soy and Fish Oil (from tuna oil).
WARNING: Accidental overdose of iron-containing products is the leading cause of fatal poisoning in children under six. Keep this and all drugs out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
Multi-Nate 30 DHA 275/400 mg supplies important prenatal vitamins, minerals and nutrients to supplement the nutritional needs of women, before, during and after pregnancy. Deficiencies of these nutrients are common during pregnancy and lactation and should be prescribed by a physician prior to conception.
Multi-Nate 30 tablet is manufactured in a drug-certified cGMP (current Good Manufacturing Practices) facility and meets or exceeds USP standards for potency, purity and dissolution. Multi-Nate DHA 275/400 mg softgel capsule complies with the most stringent worldwide standards for fish oil and is manufactured in a NSF Certified cGMP Facility.
Indications and Usage for Multi-Nate DHA
Multi-Nate 30 DHA 275/400 mg is a prescription regimen of prenatal multivitamin, multi-mineral and omega-3 fatty acid supplements indicated for use in improving the nutritional status of women throughout pregnancy and in the post-natal period for both lactating and non-lactating mothers. Multi-Nate 30 DHA 275/400 mg is also useful in improving the nutritional status prior to conception.
Multi-Nate DHA Dosage and Administration
Before, during and after pregnancy, adult women (over 12 years of age), take one (1) tablet and one (1) softgel capsule by mouth daily, between meals or as prescribed by a physician. Tablet and softgel capsule may be taken separately. Do not exceed the recommended dosage. Do not administer to children under 12 years of age or persons age 65 or older. Do not exceed one gram (1,000 mg) of DHA per day.
Contraindications
Multi-Nate 30 DHA 275/400 mg is contraindicated in patients with a known hypersensitivity to any of the ingredients, including fish oil and soy. Iron is contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. This product is contraindicated for persons with pernicious anemia, as folic acid may obscure its signs and symptoms.
WARNING: Folic acid alone is improper therapy in the treatment of pernicious anemia in that hematological remission can occur while neurological manifestations remain progressive.
Warning
Ingestion of omega-3 fatty acids (including alpha-linolenic acid [ALA], eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA] from fish oils) of more than 3 grams per day may present antithrombotic effects, including increased bleeding time. Omega-3 fatty acids including DHA and EPA should be avoided in patients with inherited or acquired bleeding diatheses. Patients taking anticoagulant drug products should consult with their physician prior to ingesting omega-3 fatty acids.
Precautions
Folic acid in dosages above 400 mcg daily may obscure megaloblastic (pernicious) anemia in that hematological remission can occur while neurological manifestations (Addisionian anemia) remain progressive.
Adverse Reactions
Iron: Gastrointestinal disturbances (anorexia, nausea, diarrhea, constipation) can occur but are usually mild and can subside with continuation of therapy. Although the absorption of iron is best when taken between meals, Multi-Nate 30 DHA 275/400 mg, when taken after meals, may control occasional G.I. disturbances, Multi-Nate 30 DHA 275/400 mg is best absorbed when taken at bedtime.
Folic Acid: Allergic sensitizations have been reported following both oral and parenteral administration of folic acid.
Call your doctor for medical advice about side effects. You may report suspected side effects to the FDA at: 1-800-FDA-1088.
USE IN SPECIFIC POPULATIONS
Multi-Nate 30 DHA 275/400 mg is not advocated for pediatric or geriatric use.
OVERDOSE
Iron: Signs and Symptoms: Iron is toxic. Acute overdosage of iron may cause nausea and vomiting. In severe cases, iron overdose can cause cardiovascular collapse and death. Other symptoms include pallor and cyanosis, melena, shock, drowsiness and coma. The estimated overdose of orally ingested iron is 300mg/kg body weight. When overdoses are ingested by children, severe reactions, including fatalities have resulted. Multi-Nate 30 DHA 275/400 mg should be stored beyond the reach of children to prevent against accidental iron poisoning. Keep this and all other drugs out of reach of children. Treatment: For specific therapy, exchange transfusion and chelating agents should be used. For general management, perform gastric lavage with sodium bicarbonate solution or milk. Administer intravenous fluids and electrolytes and use oxygen.
How is Multi-Nate DHA Supplied
Multi-Nate 30 DHA 275/400 mg NDC: 68032-445-30 is a 30-day regimen supplied as one bottle of Multi-Nate 30 NDC: 68032-316-30, containing 30 dark pink tablets imprinted “RE 316” and one bottle of Multi-Nate DHA 275/400 mg NDC: 68032-449-30, containing 30 yellow softgel capsules. Dispense in tight, light-resistant containers as defined in the USP/NF with child resistant closures. Store at controlled room temperature 15°-30°C (59°-86°F). Keep in a cool, dry place.
CAUTION: Rx Only
PACKAGING
Sample Carton Packaging (68032-445-30):
Sample Labeling (68032-316-30):
Sample Labeling (68032-449-30):
| MULTINATE DHA beta carotene, ascorbic acid, cholecalciferol, alpha-tocopherol, thiamine mononitrate, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, cyanocobalamin, calcium carbonate, iron, magnesium oxide, zinc oxide, cupric oxide, omega-3-acid ethyl esters, doconexent kit | |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| Marketing Information | |||
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| unapproved drug other | 09/01/2009 | 11/30/2012 | |
| Labeler - River's Edge Pharmaceuticals, LLC (133879135) |
More Multi-Nate DHA resources
- Multi-Nate DHA Side Effects (in more detail)
- Multi-Nate DHA Use in Pregnancy & Breastfeeding
- Multi-Nate DHA Drug Interactions
- 0 Reviews for Multi-Nate DHA - Add your own review/rating
- Advance Care Plus Concise Consumer Information (Cerner Multum)
- Cal-Nate MedFacts Consumer Leaflet (Wolters Kluwer)
- CareNatal DHA MedFacts Consumer Leaflet (Wolters Kluwer)
- CitraNatal 90 DHA MedFacts Consumer Leaflet (Wolters Kluwer)
- Duet DHA with Ferrazone MedFacts Consumer Leaflet (Wolters Kluwer)
- Folbecal MedFacts Consumer Leaflet (Wolters Kluwer)
- Gesticare DHA MedFacts Consumer Leaflet (Wolters Kluwer)
- MultiNatal Plus MedFacts Consumer Leaflet (Wolters Kluwer)
- Multifol Plus Concise Consumer Information (Cerner Multum)
- Neevo Caplets MedFacts Consumer Leaflet (Wolters Kluwer)
- Neevo DHA MedFacts Consumer Leaflet (Wolters Kluwer)
- OB Complete 400 MedFacts Consumer Leaflet (Wolters Kluwer)
- PreNexa MedFacts Consumer Leaflet (Wolters Kluwer)
- Prenate Elite tablets
- Prenate Elite MedFacts Consumer Leaflet (Wolters Kluwer)
- PrimaCare Advantage MedFacts Consumer Leaflet (Wolters Kluwer)
- PrimaCare ONE capsules
- PrimaCare One MedFacts Consumer Leaflet (Wolters Kluwer)
- Se-Natal 19 Chewable Tablets MedFacts Consumer Leaflet (Wolters Kluwer)
- Triveen-One MedFacts Consumer Leaflet (Wolters Kluwer)
- Ultra NatalCare MedFacts Consumer Leaflet (Wolters Kluwer)
- Vitafol-One MedFacts Consumer Leaflet (Wolters Kluwer)
Compare Multi-Nate DHA with other medications
- Vitamin/Mineral Supplementation during Pregnancy/Lactation
No comments:
Post a Comment